Purchase Order 75N91023P00704
Award Date 8/27/23
Potential Completion Date 8/26/24
Potential Value $24K
Federal Agency
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $16,761.96 firm fixed price purchase order to Becton, Dickinson and Company for maintenance services with a period of performance through August 2024. As the prime contractor, Becton, Dickinson and Company will provide maintenance under this order through its BD Biosciences division located in Rockville, Maryland. No set-aside designation was used for this award to support the...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division a $13,713.30 firm fixed price purchase order for bridge maintenance agreement services. BD Biosciences will perform the services in Bethesda, Maryland over a period of four months concluding in December 2023. As the prime contractor, BD Biosciences specializes in providing research reagents and instruments that...
- Becton, Dickinson and Company (BD) has been awarded a firm fixed price purchase order by the National Institutes of Health National Cancer Institute for $10,864.80. The contract calls for servicing an instrument used by approximately 75 personnel at the agency to conduct experiments involving costly reagents, animals, and extensive labor hours. Performance will take place in Bethesda, Maryland through April 2024. No set-aside designation was applied. This award is likely associated with...
- This is a federal contract award to Becton, Dickinson and Company (BD) by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), for maintenance services on government-owned Becton Dickinson instrumentation. The $141,480.00 firm fixed-price purchase order supports the work of the NCI's Center for Cancer Research, Experimental Immunology Branch. The contract has no set-aside designation and was awarded on February 1, 2017, with a completion date of January...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm-fixed-price delivery order to Becton, Dickinson and Company, a leading global medical technology company, to provide reagents, rental equipment, product supply, and maintenance for equipment in the laboratory of pathology. The contract has a potential value of $149,988.00 and a completion date of August 23, 2019. Becton, Dickinson and Company, operating through its IDS division as...
- This federal contract award to Becton, Dickinson and Company (BD), a leading medical technology manufacturer, is for the provision of BD Biosciences instrument rental, reagents, quality control material, and instrument supplies to the National Cancer Institute, a component of the Department of Health and Human Services. The contract, valued at $149,960.30, is a delivery order awarded under a larger indefinite delivery/indefinite quantity (IDIQ) vehicle. It does not have a set-aside...
- Becton, Dickinson and Company, through its BD Biosciences division, was awarded a delivery order maintenance agreement by the National Cancer Institute valued at $154,840.80 under the Multiple Award Schedule on February 1, 2023. This firm fixed-price contract, with an ultimate completion date of January 31, 2028, provides maintenance services for specialized laboratory instrumentation at the National Cancer Institute's Bethesda, Maryland facility. The award is part of BD's broader portfolio of...
- The National Institutes of Health's National Cancer Institute awarded Becton, Dickinson and Company a $11,681 purchase order contract to provide reagents. The contract has a period of performance from July 11, 2023 through December 26, 2023 and utilizes a firm fixed price payment structure. Reagents will be delivered to Becton, Dickinson and Company's facility in Franklin Lakes, New Jersey to support the National Cancer Institute's research efforts. No subcontractors or set aside designations...
- The National Cancer Institute (NCI), a component of the National Institutes of Health under the Department of Health and Human Services, awarded a firm fixed-price purchase order to Becton, Dickinson and Company (BD), through its BD Biosciences division, for preventive maintenance services on a government-owned BD LSRFortessa Flow Cytometer. This contract, valued at $144,941.40, represents the exercise of Option Period One under the original maintenance agreement and extends through August 31,...
- Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, was awarded a Firm Fixed Price contract by the National Cancer Institute (NCI) on May 3, 2017, with a ceiling value of $17,928.00. This contract was executed as a Blanket Purchase Agreement (BPA) call without small business set-aside designation, reflecting BD's competitive standing as a large, established medical technology manufacturer. The work was to be performed in Bethesda, Maryland, with an...